|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
+ b: c0 p5 B- u Y3 C1 Twas to close its brain research facility in Basel, Switzerland,
, n; U$ x+ W7 A1 }5 {2 ethe story noted that this move closely followed similar cuts
( \0 j# X7 h( [: c/ {0 Oby rival pharmaceutical firms. As a report from the European College# o0 f/ ]. ]: L6 N1 c, H
of Neuropsychopharmacology/ X7 S: R3 f3 Q u, T& x: R
had warned a few months earlier, the
& I' e* p6 ?: F. rabandonment of research into new psychiatric drugs by AstraZeneca,2 g7 n/ \5 U, \# e% @: V
GlaxoSmithKline/ b6 m0 a- p; v9 \. N( a
and others meant that “withdrawal of research
9 G" H) g. C( A. `9 Dresources is a withdrawal of hope for patients and their families”.( |% D0 v6 C9 e+ d
0 \2 s- [. ]" w- f; X8 j. o3 u8 V) H' \6 e' J
回复有免费下载链接3 P8 ~; @8 B0 N& o8 ?& m) ?
* ~& L6 M6 |( O& ?3 u
|
-
总评分: 包包 + 20
查看全部评分
|